Skip to main content
Log in

Intensified cancer chemotherapy by induction of hepatic drug-metabolizing enzymes as a trial for the treatment for stomach cancer

  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

Studies of an intensified chemotherapy of FT-207, combined with MMC, have been under way since April 1977 in the First Department of Surgery of Chiba University Hospital and five closely related hospitals. These studies were performed on 114 patients with curative stomach cancer. The 114 patients received intravenously 0.4 mg/kg and 0.2 mg/kg of MMC on the operation day and the next day, respectively, and then intravenously 800 mg of FT-207 daily from the 10th postoperative day until discharge, followed by oral administration of FT-207, 600 mg, for more than 1 year after discharge. The 114 patients were divided into two groups. Half of the patients received 100 mg of phenobarbital and 30 mg/kg of glutathione for the purpose of induction of hepatic drug-metabolizing enzymes (induction group). Significantly higher levels of serum 5-FU released from FT-207 were observed in the patients of the induction group when compared to those of the control group. However, there was no statistically significant difference in survivals at both 12 and 24 months after operation between both groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Breckenridge, A., Orme, M.L’E., Davies, L., Thorgeirsson, S. S. and Davies, D. S.: Dosedependent enzyme induction,Clin. Pharmacol. Ther. 14: 514–520, 1973.

    PubMed  CAS  Google Scholar 

  2. Ernster, L. and Orrenius, S.: Substrate-induced synthesis of the hydroxylating enzyme system of liver microsomes,Fed. Proc. 24: 1190–1199, 1965.

    PubMed  CAS  Google Scholar 

  3. Fujii, S., Okuda, H., Toide, H., Watanabe, N., Taira, K. et al.: Studies on the fate of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207), a new antitumor agent (1). Absorption, tissue distribution and excretion,Ohyo-Yakuri 8: 589–595, 1974 (in Japanese).

    CAS  Google Scholar 

  4. Fujimoto, S., Akao, T., Itoh, B., Koshizuka, I., Kitsukawa, Y. et al.: Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer,Ann. Surg. 185: 462–466, 1977.

    PubMed  CAS  Google Scholar 

  5. Fujimoto, S., Ishigami, H., Minami, T., Miyazaki, M., Itoh, K. et al.: Metabolism of 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil in mice.J. Natl. Cancer Inst. 63: 465–468, 1979.

    PubMed  CAS  Google Scholar 

  6. Fujimoto, S., Itoh, K., Tazawa, T., Ichimura, K., Hosaka, T. et al.: Studies on protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer, with special reference to cancer chemotherapy by hepatic microsomal enzyme induction,Jpn. J. Surg. Soc. 79: 1099–1104, 1978 (in Japanese).

    Google Scholar 

  7. Fujita, H.: In vivo distribution of antitumor agents—methods of assay (1)—Cancer and Chemotherapy 1: 497–503, 1974 (in Japanese).

    Google Scholar 

  8. Garfinkel, D.: Pig-liver microsomes. I. Enzymic and pigment composition of different microsomal fractions,Arch. Biochem. Biophys. 77: 493–509, 1958.

    Article  PubMed  CAS  Google Scholar 

  9. Hattori, T., Itoh, I., Miwa, K., Hirata, K., Fujita, H. et al.: Large amount administration of mitomycin C during gastrectomy,Jpn. J. Cancer Clin. 10: 96–105, 1964 (in Japanese).

    CAS  Google Scholar 

  10. Hattori, T., Mori, A., Hirata, K. and Itoh, I.: Five year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin C, and/or allogeneic bone marrow transplantation,Jpn. J. Cancer Clin. 19: 241–248, 1973 (in Japanese with English abstract).

    Google Scholar 

  11. Kaibara, N., Soejima, K., Nakamura, T. and Inokuchi, K.: Postoperative long term chemotherapy for advanced gastric cancer,Jpn. J. Surg. 6: 54–59, 1976.

    Article  PubMed  CAS  Google Scholar 

  12. Klingenberg, M.: Pigment of rat-liver microsomes,Arch. Biochem. Biophys. 75: 376–386, 1958.

    Article  PubMed  CAS  Google Scholar 

  13. Koshizuka, I.: Studies on the metabolism of N1-(2-tetrahydrofuryl)-5-fluorouracil in vivo influenced by phenobarbital and glutathione,Jpn. J. Cance Clin. 24: 127–132, 1978 (in Japanese with English abstract).

    Google Scholar 

  14. Ohira, S.: Cancer chemotherapy in relation to the level of microsomal drug-metabolizing enzymes (cytochrome P-450) in the liver,Jpn. J. Cancer Clin. 23: 720–733, 1977 (in Japanese with English abstract).

    CAS  Google Scholar 

  15. Wills, E. D.: Lipid peroxide formation in microsomes. General consideration,Biochem. J. 113: 315–324, 1969.

    PubMed  CAS  Google Scholar 

  16. Wills, E. D.: Lipid peroxide formation in microsomes. Relationship of hydroxylation to lipid peroxide formation,Biochem. J. 113: 333–341, 1969.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujimoto, S., Itoh, K., Tazawa, T. et al. Intensified cancer chemotherapy by induction of hepatic drug-metabolizing enzymes as a trial for the treatment for stomach cancer. The Japanese Journal of Surgery 10, 27–33 (1980). https://doi.org/10.1007/BF02468643

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02468643

Key Words

Navigation